Roche eyes Gazyva label expansion on positive Phase III kidney disease data
If Gazyva gains approval in membranous nephropathy, it would have four approved indications under its belt as the drug’s patent expiry looms.
MEDIPOST files IND amendment to FDA for Phase III osteoarthritis trial
BridgeBio looks to challenge BioMarin in dwarfism market on Phase III win
Lundbeck’s migraine prevention drug meets primary endpoint in Phase IIb trial
Centivax begins participant dosing in Phase Ia flu vaccine trial
Lyell doses first patient in Phase III trial for LBCL
Analysis
View More
Themes
View MoreOncology trial systems debut at SCOPE 2026 as AI adoption accelerates
Massive Bio and ConcertAI revealed the AI oncology trial systems at SCOPE 2026.
More themes
Data Insights
View MoreLeading innovators with viral vectors for the pharmaceutical industry
The pharmaceutical industry continues to be a hotbed of innovation, with activity driven by the evolution of new treatment paradigms,...
Discover Data Insights powered by our proprietary data
Understand the themes driving your sector, keep up with key innovation areas and track the activities of leading companies
More Insights
Buyer's Guides
View More
GlobalData Reports
View more
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Biorce secures $52.5m in Series A to expand AI clinical trial tech
Revealing the human and business cost of clinical trial inefficiencies for Data Managers and CRAs
Patient-centric approaches thrive on wearables and remote access in trials
Pharma’s AI prospects get nudged into the future with EU’s AI act